Stockreport

Therapix Biosciences Announces Positive Topline Results From Phase IIa Clinical Trial of THX-110 for Obstructive Sleep Apnea Program

THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE  (TRPX) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/trpx
PDF TEL AVIV, Israel, Nov. 13, 2019 /PRNewswire/ -- Therapix Biosciences Ltd. ("Therapix" or the "Company") (Nasdaq: TRPX), a specialty, clinical-stage pharmaceutical compan [Read more]